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Intestinal ischemic injury is a signiﬁcant clinical problem arising from diseases or as a complication
of abdominal surgery. Our previous study showed aquaporin 3 is involved in intestinal barrier
impairment. Here, we revealed that intestinal ischemia induced a time-dependent increase of
miR-874 expression and a time-dependent decrease of AQP3 expression, and the level of miR-874
expression was inversely related to AQP3 protein expression. In addition, miR-874 promoted the
paracellular permeability in vitro through targeting 30UTR of AQP3. Two of the tight junction
proteins, Occludin and Claudin-1, were found to be involved in miR-874-induced intestinal barrier
dysfunction.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Ischemic injury is observed in a variety of diseases, such as vas-
cular occlusion, haemorrhagic shock or trauma [1,2]. Many lines of
evidence support the concept that ischemic injury may initiate a
series of intestinal reactions such as intestinal barrier dysfunction,
translocation of intestinal bacteria, or even cause systemic inﬂam-
matory response syndrome (SIRS) [3]. The mechanism of intestinal
mucosal barrier is very complicated, which may constitute of
mechanical barrier, immune barrier, chemical barrier and biologi-
cal barrier [4]. However, the underlying molecular mechanism of
the intestinal barrier dysfunction following ischemia has remained
poorly understood.
AQPs (aquaporins) are a family of small (30 kDa/monomer)
hydrophobic, integral membrane proteins, which belong to a spe-
cial superfamily of MIPs (major intrinsic proteins) [5]. AQP3 is
mainly expressed in the epithelia of the upper and lower digestive
tract and acts as membrane channels for the selective transport of
water, glycerol and other small solutes across the cell membrane
[6]. We recently demonstrated that down-regulation of AQP3 inCaco-2 cells contributed signiﬁcantly to impair the intestinal bar-
rier integrity via opening the tight junction complex. [7]. However,
the mechanism by which AQP3 is regulated and the expression
level of AQP3 after ischemic injury are still unclear.
MicroRNAs are approximate 20 nucleotides RNA molecules that
play a role in modulating the activity of thousands of genes [8].
Recently, a role for microRNAs in the regulation of intestinal bar-
rier has begun to be explored. McKenna et al. [9] demonstrated
that employing gene ablation of Dicer 1 induced intestinal barrier
dysfunction and inﬂammation in mice. Our previous study showed
that miR-874 suppressed AQP3 expression by binding to the 30UTR
of AQP3 mRNA in gastric cancer cells [10]. In this study, we inves-
tigated the expression pattern of miR-874 and AQP3 in mice with
intestinal ischemic injury and then conﬁrmed the effect of miR-874
on the regulation of intestinal barrier through targeting AQP3.
2. Materials and methods
2.1. Intestinal ischemic injury
C57BL/6 mice were purchased from the Shanghai Experimental
Animal Center (Chinese Academy of Sciences, Shanghai, China) and
housed under controlled conditions of temperature and humidity.
Forty 8-week-old mice were randomized into sham group,
ischemic group (15 min), ischemic group (30 min) and ischemic
group (45 min). After intraperitoneal anesthesia with 40 mg/kg
758 X. Zhi et al. / FEBS Letters 588 (2014) 757–763pentobarbital, the abdomen was opened and the superior
mesenteric artery (SMA) was occluded for 15, 30 or 45 min using
non-traumatic vascular clamps in each ischemic group without
reperfusion. Animals in the sham group underwent identical pro-
cedures without SMA occlusion. After those procedures, 10 cm of
jejunum was obtained for western blot and quantitative real-time
PCR analyses. All experiments were approved and monitored by
the institutional animal care and use committee of Nanjing
Medical University.
2.2. Cell culture assays
Caco-2 cells and LS174T cells were purchased from Chinese
Academy of Sciences and were cultured in DMEM (Gibco, Carlsbad,
CA, USA) containing 10% fetal bovine serum (Gibco, Uruguay),
100 mg/ml penicillin and 100 mg/ml streptomycin (Gibco, NY,
USA) at 37 C with 5% CO2. To form the Caco-2 monolayer,
2  105 Caco-2 cells were seeded onto the apical chamber of Trans-
well bicameral chamber containing 0.4 lm pores. The cells were
grown for 14 days to allow them to reach conﬂuence and fully dif-
ferentiate. The medium was changed every other day.
Hypoxia was induced in vitro by incubating the cells in anaero-
bic chambers. Cells were placed in an airtight container (Thermo
Scientiﬁc) and maintained at 37 C in humidiﬁed atmosphere con-
taining 1% O2 and 10% CO2. Media were equilibrated for 24 h to the
required oxygen level in the hypoxia workstation in the same con-
ditions before use.
2.3. Lentivirus production and cell transfection
We modiﬁed the commercial LV3-has-miR-874-premicroRNA
vector (pre-miR-874) and LV3-has-miR-874-sponge inhibitor vec-
tor (miR-874 inhibitor) lentiviral constructs (Genepharma, Shang-
Hai, China) to overexpress or knockdown miR-874 in Caco-2 and
LS174T cells. LV3 empty lentiviral construct (miR-NC) served as a
negative control. Retrovirus packaging and infection were con-
ducted as described previously [10].
2.4. Luciferase assay
The 30UTR of AQP3 complementary DNA containing the wild-
type or mutated miR-874 binding sequences were synthesized by
Shenggong (Shanghai, China). The sequence was cloned into the
FseI and XbaI restriction sites of the pGL3 luciferase control repor-
ter vector (Promega, USA) to generate the AQP3 30UTR reporter.
Total 5  105 Caco-2 and LS174T cells stably transfected with
pre-miR-874 or miR-NC were seeded in 24-well plates. Cells were
transfected with 0.12 lg of either pGL3-WT-AQP3 or pGL3-MUT-
AQP3 30UTR reporter plasmid. Meanwhile, 0.01 lg of Renilla
luciferase expression plasmid was also transfected into the above
cells as a reference control. Fireﬂy and Renilla luciferase activities
were measured by Dual-Luciferase reporter assay (Promega,
E1910, WI, USA) at 36 h after transfection according to the
manufacturer’s instruction. The relative luciferase activity was
calculated as ﬁreﬂy ﬂuorescence/Renilla ﬂuorescence.
2.5. Quantitative real-time PCR
Quantitative real-time PCR was performed as previously
described [10]. TaqMan gene expression assays for murine and
human AQP3 and speciﬁc TaqMan probes (Genepharma, ShangHai,
China) to quantify miR-874 were used. Gene expression levels
were normalized to the level of b-actin and snRNA U6. Results
were calculated using the 2DDCt method. All experiments were
done independently in triplicate.2.6. Western blot assay
Antibodies against AQP3 (Abcam), Clauding-1 (Cell Signalling
Technology), Occludin (Abcam), Claudin-2 (Abcam), Zo-1 (Cell
Signalling Technology), E-cadherin (Cell Signalling Technology)
and beta-catenin (Cell Signalling Technology) were used. Protein
were separated on the 10% SDS polyacrylamide gel and
transferred to 0.2-mm nitrocellulose membrane which was then
blocked in TBST (10 mM Tris–HCl, pH 7.5, 150 mM NaCl, and
0.1% Tween 20) containing 5% milk. Blots were incubated with
speciﬁc ﬁrst antibodies in dilution buffer at 4 C overnight. The
blotted membranes were then incubated with HRP-conjugated
anti-mouse or antirabbit IgG (Cell Signalling Technology) at room
temperature for 2 h. Targeting protein expression levels were
detected using an enhanced chemiluminescence (ECL) detection
system following the manufacturer’s instructions. GAPDH was
used as an internal control.
2.7. Measurement of the transepithelial electrical resistance
The formation of a monolayer of Caco-2 cells was monitored
by the measurements of the transepithelial electrical resistance
(TEER) with a Millicell electrical resistance system (Millipore,
Bedford, MA) as described previously [7]. Brieﬂy, immerse the
electrodes so that the shorter electrode is in the Millicell cul-
ture plate insert and the longer electrode is in the outer well.
The shorter electrode should not contact cells growing on the
membrane. All experiments were done independently in
triplicate.
2.8. Detection of paracellular permeability
Monolayers were used in this experiment only after the TEER
had risen above 150X/cm2. Generally, about 14 days of culture
are needed to reach such a TEER. Paracellular permeability was as-
sessed by measuring the ﬂux of lucifer yellow (LY) from apical to
basal chambers of the Transwell [11]. LY was diluted in transport
buffer (HBSS with Ca2+, Mg2+, +10 mM HEPES, pH 7.4) and added
to the apical chamber at a ﬁnal concentration of 50 lM. Three
hours later, LY concentration in the basal chamber was measured
with TECAN Inﬁnite F500 (Männedorf, Switzerland) luminescence
spectrometer against a standard concentration curve (excitation
427 nm, emission 536 nm).
2.9. Bacterial translocation
The DMEM used to culture the cells was removed from the
bicameral chamber and replaced with fresh HBSS. An inocu-
lums containing 105 bacteria (Escherichia coli C25) was added
to the apical side of the Caco-2 cell monolayer that had been
grown in culture for 14 days. Bacterial translocation was eval-
uated by quantitatively culturing samples of medium (100 ll)
obtained from the basal chamber at 20, 40, 120, and 180 min
after adding bacteria. The number of viable translocation E.
coli C25 was quantitated by pour late assay with Macconkey’s
agar.
2.10. Statistical analysis
Data are expressed as means ± S.D. Differences were
analysed with the unpaired Student’s t test and Analysis of
variance (ANOVA). A value of P < 0.05 was considered statisti-
cally signiﬁcant. Statistics were performed using SPSS version
19.0 for windows.
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3.1. Changes of AQP3 and miR-874 expression in a mouse model of
acute intestinal ischemia
Western blot and quantitative real-time PCR were performed to
detect the AQP3 and miR-874 expression. Results showed that
ischemia induced a time-dependent increase of miR-874 expres-
sion and a time-dependent decrease of AQP3 expression (Fig. 1A).
Notably, we found that the level of miR-874 expression was inver-
sely related to AQP3 protein expression after 30 min of intestinal
ischemia (Fig. 1B). These data indicated that miR-874 might have
an impact on AQP3 expression and intestinal barrier.
3.2. Expression pattern of miR-874 and AQP3 in Caco-2 cells under
hypoxic or serum-free conditions
Similarly, the protein level of AQP3was signiﬁcantly reduced and
the level of miR-874 was increased in a time-dependent manner in
condition of hypoxia or serum-free (Fig. 1C and D). In addition, the
variation of miR-874 and AQP3 seemed more sensitive to hypoxia.
After 8 h of hypoxia, the level of miR-874 and AQP3 showed a
tendency towards stabilization (Fig. 1C and D). Correlation analysis
further suggested that the level ofmiR-874expressionwas inversely
related to AQP3 protein expression in condition of hypoxia. The
expression ofmiR-874 and AQP3 showed a tendency towards corre-
lation, but did not get a signiﬁcant P value (Fig. 1E).
3.3. miR-874 directly interacts with the 30UTR of AQP3 in Caco-2 and
LS174T cells
Our previously study revealed that miR-874 decreased AQP3
expression in gastric cancer cells by targeting its 30UTR [10]. Bioin-
formatic analysis showed the miR-874 binding site in 30UTR of
AQP3 (Fig. 2G). Wild-type (WT) and mutant (MUT) 30UTR of AQP3
were cloned into the luciferase reporter. The ﬂuorescent activity
of the reporter was signiﬁcantly declined in the cells that were
transfected with pGL3-WT-AQP3 30UTR in Caco-2 cells and
LS174T cells stably transfected with pre-miR-874 (Fig. 2H and
Fig. S1). The ﬂuorescent activity did not change signiﬁcantly in
the cells transfected with pGL3-MUT-AQP3 30UTR.
To further investigate the impact of miR-874 on AQP3 expres-
sion in Caco-2 and LS174T cells, we performed both miR-874 over-
expression and knockdown experiments. Silence of miR-874
resulted in the up-regulation of AQP3 protein compared with the
negative control. Conversely, the protein level of AQP3 was signif-
icantly down-regulated after transfection with pre-miR-874
(Fig. 2H).
3.4. miR-874 inhibits MUC2 expression in LS174T cells
MUC2 has been proven to play an important role in intestinal
barrier. We investigated that MUC2 was signiﬁcantly inhibited
after miR-874 overexpression in LS174T cells (Fig. 2A), which
was a ideal in vitro model for studying MUC2 expression [12].
The results indicated miR-874 might also affect mucus barrier.
3.5. miR-874 promotes intestinal barrier dysfunction in vitro
Overexpression of miR-874 in Caco-2 cells caused an increase of
paracellular permeability, as measured by decreased TEER and in-
creased LY permeability (Fig. 2B and C). These effects were time-
dependent.
E. coli translocation assay was performed after the cells had
grown for 14 days to allow them to reach conﬂuence and fullydifferentiate. We found that Caco-2 cells with miR-874 overexpres-
sion showed more E. coli translocation than negative control at
each time point (Fig. 2D).
TNF-a is a main factor to mediate the intestinal barrier dysfunc-
tion. We observed the role of miR-874 in TNF-a-mediated
intestinal barrier dysfunction. Overexpression of miR-874 in
Caco-2 cells promoted the increase of paracellular permeability
caused by TNF-a (Fig. 2E and F).
3.6. miR-874 alters the expression of the tight junction proteins
The tight junction proteins were detected by western blot to
investigate the mechanism of miR-874-induced intestinal barrier
dysfunction with or without TNF-a. The results showed that Occlu-
din and Claudin-1 were signiﬁcantly increased in Caco-2 cells trea-
ted with miR-874 inhibitor compared with the negative control. By
contrast, miR-874 overexpression suppressed Occludin and Clau-
din-1 expression. Expression of the other tight junction proteins,
such as ZO-1, Claudin-2, E-cadherin and beta-catenin, did not
change signiﬁcantly (Fig. 3). TNF-a had little effect on the expres-
sion of tight junction proteins.
4. Discussion
Intestinal ischemic injury is a signiﬁcant clinical problem aris-
ing from diseases or as a complication of abdominal surgery [13].
The intestinal mucosa is particularly susceptible to ischemic injury.
Intestinal barrier dysfunction resulting from mucosal ischemia has
also been observed and might contribute to the progression of
intestinal lesions, or even cause systemic inﬂammatory response
syndrome (SIRS) [14]. A ﬁrm association between AQP3 and intes-
tinal barrier dysfunction has been established in our previous
study [7]. Recently, a role for microRNAs in the regulation of intes-
tinal barrier has begun to be explored [9,15]. Silence of Dicer 1
caused intestinal barrier dysfunction and inﬂammation in mice
[9]. Our previous study showed that miR-874 suppressed AQP3
expression by binding to the 30UTR of AQP3mRNA in gastric cancer
cells [10]. In this study, we investigated the expression pattern of
miR-874 and AQP3 in a mouse model of acute intestinal ischemia,
and then conﬁrmed the effect and underlying mechanism of miR-
874 on regulation of intestinal barrier. Our results revealed that
ischemia induced a time-dependent increase of miR-874 expres-
sion and a time-dependent decrease of AQP3 expression, and the
level of miR-874 expression was inversely related to AQP3 protein
expression. In addition, miR-874 promoted the paracellular perme-
ability in vitro through targeting 30UTR of AQP3. Two of the tight
junction proteins, Occludin and Claudin-1, were found to be
involved in miR-874-induced intestinal barrier dysfunction.
Most intestinal mucosal surfaces are covered by a hydrated gel
formed by MUC2, which creates a barrier that prevents large
particles, including most bacteria, from directly contacting the
epithelial cell layer [16]. Grootjans et al. [17] were the ﬁrst to show
that colonic ischemia lead to loss of the mucus layer and conse-
quently allowed adherence of bacteria to the epithelium and trans-
location of potential pathogens and their toxins to the internal
milieu. In the present study, the expression of MUC2 in LS174T
cells was signiﬁcantly suppressed by miR-874 overexpression.
We searched TargetScan, PicTar and miRanda databases to conﬁrm
whether MUC2 contains putative targets of miR-874. We did not
ﬁnd any correlation between MUC2 and miR-874. However, we
found that miR-874 could bind to the 30UTR of STAT3, which was
crucial to production of MUC2 in LS174T cells by suppressing pro-
tein misfolding and endoplasmic reticulum stress. So we assumed
that intestinal ischemia and hypoxia induced miR-874 up-regula-
tion, resulting in STAT3 inhibition through targeting its 30UTR,
Fig. 1. Expression pattern of miR-874 and AQP3 in a mouse ischemia model or cellular hypoxia model. (A) The superior mesenteric artery (SMA) was occluded for 15, 30 and
45 min using non-traumatic vascular clamps in the mouse ischemia model. Each group included 10 mice. Western blot and quantitative real-time PCR were used to detect the
expression of miR874 and AQP3. (B) The scatter plots show the expression of miR-874 and AQP3 in each group. Linear regression analysis was used to measure the association
between miR-874 and AQP3. (C–E) Hypoxia was induced in vitro by incubating the Caco-2 cells in anaerobic chambers containing 1% O2 and 10% CO2. Western blot and
quantitative real-time PCR were used to detect the expression of miR874 and AQP3. Linear regression analysis was used to measure the association between miR-874 and
AQP3. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
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Fig. 2. Intestinal barrier dysfunction caused by miR-874. (A) MUC2 was inhibited by overexpression of miR-874. (B–D) The formation of a monolayer of Caco-2 cells was
monitored by the measurements of the transepithelial electrical resistance (TEER), lucifer yellow (LY) permeability and bacterial translocation. (E and F) TNF-a was added
after the cells had grown for 14 days. Overexpression of miR-874 in Caco-2 cells promoted the increase of paracellular permeability caused by TNF-a. (G) The AQP3 30UTR
regions containing the wild-type or mutant binding site for miR-874 are shown. (H) Relative AQP3 luciferase activity was analyzed after the wild-type or mutant 30UTR
reporter plasmids were transfected into Caco-2 and LS174T cells stably transfected with miR-NC or pre-miR-874. Western blot was used to analyze the expression levels of
AQP3. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
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However, the underlying mechanism remains further studies.
Tumor necrosis factor-a (TNF-a) is an essential mediator of
inﬂammation in the gut [18,19]. In addition, TNF-a has beenshown to cause an increase in intestinal tight junction permeabil-
ity, which allows increased intestinal penetration of luminal anti-
gens [20–22]. However, the interaction between intestinal
ischemia and TNF-a remains unclear. We have developed a
Fig. 3. The expression of tight junction proteins was detected by western blot. The
cells were treated with TNF-a (10 ng/ml) for 12 h.
762 X. Zhi et al. / FEBS Letters 588 (2014) 757–763cultured epithelial monolayer system in vitro. Based on TEER
and LY permeability results, it appeared that the Caco-2 cells re-
quired approximately 14 days of culture to form a tight monolayer.
TNF-a was added when the cells formed a tight monolayer. Our
results showed that overexpression of miR-874 promoted the
increase of paracellular permeability caused by TNF-a, indicating
that miR-874 overexpression and inﬂammation caused by ische-
mia might interact and promote the damage of intestinal barrier
cooperatively. To further investigate the underlying mechanism,
we tested the expression of tight junction proteins.
Tight junctions (TJ) are the major determinants of paracellular
permeability in the intestinal. Previous studies have revealed that
intestinal injury alters the distribution of TJ proteins [23,24].
Enhancement of the TJ barrier prevents the development of intes-
tinal inﬂammation [25,26]. Occludin is the ﬁrst TJ protein to be
reported [27]. Knockdown of Occludin leads to an increase in intes-
tinal TJ permeability via a non-restrictive manner [28]. In the
recent studies, ischemia/reperfusion resulted in the disruption of
Claudin-1 and ZO-1 [23,29]. Our results showed Occludin and
Claudin-1 were signiﬁcantly increased in Caco-2 cells treated with
miR-874 inhibitor compared with the negative control. By contrast,
miR-874 overexpression suppressed Occludin and Claudin-1
expression, which was consistent with previous ﬁndings [30,31].
All these ﬁndings further conﬁrmed that miR-874 played an
important role in intestinal barrier dysfunction in acute intestinal
ischemia.
In conclusion, this study demonstrated that intestinal ischemia
changed the expression of miR874 and AQP3 in a mouse model.
Moreover, miR-874 promoted the paracellular permeability
in vitro through targeting 30UTR of AQP3. These ﬁndings identiﬁed
miR-874 as a novel therapeutic target. Further studies are required
to reveal the possibility of interference of miR-874 expression in
the treatment for ischemic disease.
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